소화기내과이한아

전문분야
간암, 간경변, 바이러스 간염, 지방간
진료일정 외래전문센터특수클리닉
진료일정표
날짜 29(월) 30(화) 1(수) 2(목) 3(금) 4(토)
오전
오후
외래
외래
외래
외래
휴진일정
  • 2021.12.01(수) : 휴가
  • 2021.12.02(목) : 휴가
진료예약
TAG
  • #간암,간경변,바이러스간염,지방간

경력

  • 2005-2011 고려대학교 의학과 학사
  • 2014-2017 고려대학교 의학과 석사
  • 2017-2020 고려대학교 의학과 박사
  • 2016-2018 고려대학교 안암병원 소화기내과 임상강사
  • 2018-2020 고려대학교 안암병원 소화기내과 임상조교수 대우
  • 2021- 인제대학교 상계백병원 진료교수

주요활동

  • 2015- 대한내과학회 정회원
  • 2016- 대한간학회 평생회원
  • 2017- 대한간암학회 평생회원
  • 2017- 대한소화기학회 정회원
  • 2017- 대한소화기암학회 정회원
  • 2018 대한임상초음파학회 질관리위원회, 간행위원회 위원
  • 2019- 대한간학회 간행위원회 부간사, 교육위원회 위원
  • 2019 대한간암학회 간행위원회, 보험위원회 위원
  • 2019- 대한간암학회 간암등록사업위원회 간사
  • 2020- 대한간암학회 기획위원회, 보험위원회 위원

연구업적

  • 1: Lee HA, Rim CH. Efficacy of Local Treatments for Hepatocellular Carcinoma
  • Involving the Inferior Vena Cava and/or Right Atrium. J Hepatocell Carcinoma.
  • 2020 Dec 21;7:435-446. doi: 10.2147/JHC.S285357. PMID: 33376712; PMCID:
  • PMC7762452.
  • 2: Kim Y, Lee HA, Lee JS, Jeon MY, Kim BK, Park JY, Kim DY, Ahn SH, Um SH, Seo
  • YS, Kim SU. Association between curative treatment after transarterial
  • radioembolization and better survival outcomes in patients with hepatocellular
  • carcinoma. Cancer Invest. 2020 Dec 28:1-24. doi: 10.1080/07357907.2020.1870126.
  • Epub ahead of print. PMID: 33356630.
  • 3: Lee HA, Jung JY, Lee YS, Jung YK, Kim JH, An H, Yim HJ, Jeen YT, Yeon JE,
  • Byun KS, Um SH, Seo YS. Direct Bilirubin Is More Valuable than Total Bilirubin
  • for Predicting Prognosis in Patients with Liver Cirrhosis. Gut Liver. 2020 Dec
  • 9. doi: 10.5009/gnl20171. Epub ahead of print. PMID: 33293481.
  • 4: Lee HA, Park S, Seo YS, Yoon WS, Shin IS, Rim CH. Surgery versus external
  • beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava
  • or right atrium: A systematic review and meta-analysis. J Hepatobiliary Pancreat
  • Sci. 2020 Nov 11. doi: 10.1002/jhbp.865. Epub ahead of print. PMID: 33179421.
  • 5: Lee HA, Kim SU. Letter: fatty liver disease could have been a confounding
  • factor for phase change in patients with chronic hepatitis B in the immune-
  • tolerant phase-authors' reply. Aliment Pharmacol Ther. 2020 Sep;52(6):1094-1095.
  • doi: 10.1111/apt.16000. PMID: 33119164.
  • 6: Chang JW, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Seo YS, Lee HA,
  • Kim MN, Lee YR, Hwang SG, Rim KS, Um SH, Tak WY, Kweon YO, Park SY, Kim SU.
  • Validation of risk prediction scores for hepatocellular carcinoma in patients
  • with chronic hepatitis B treated with entecavir or tenofovir. J Viral Hepat.
  • 2021 Jan;28(1):95-104. doi: 10.1111/jvh.13411. Epub 2020 Oct 7. PMID: 33029863.
  • 7: Kim SU, Chon YE, Seo YS, Lee HW, Lee HA, Kim MN, Min IK, Park JY, Kim DY, Ahn
  • SH, Tak WY, Kim BK, Park SY. A multi-centre study of trends in hepatitis B
  • virus-related hepatocellular carcinoma risk over time during long-term entecavir
  • therapy. J Viral Hepat. 2020 Dec;27(12):1352-1358. doi: 10.1111/jvh.13384. Epub
  • 2020 Sep 19. PMID: 32852880.
  • 8: Lee HA, Kim SU. Letter: risk of hepatocellular carcinoma in immune-tolerant
  • phase of chronic hepatitis B-authors' reply. Aliment Pharmacol Ther. 2020
  • Sep;52(5):913-914. doi: 10.1111/apt.15992. PMID: 32852833.
  • 9: Lee HA, Lee YS, Kim BK, Jung YK, Kim SU, Park JY, Kim JH, An H, Kim DY, Yim
  • HJ, Ahn SH, Yeon JE, Byun KS, Han KH, Um SH, Seo YS. Change in the Recurrence
  • Pattern and Predictors over Time after Complete Cure of Hepatocellular
  • Carcinoma. Gut Liver. 2020 Aug 26. doi: 10.5009/gnl20101. Epub ahead of print.
  • PMID: 32839362.
  • 10: Kim SW, Yoon JS, Park J, Jung YJ, Lee JS, Song J, Lee HA, Seo YS, Lee M,
  • Park JM, Choi DH, Kim MY, Kang SH, Yang JM, Song DS, Chung SW, Kim MA, Jang HJ,
  • Oh H, Lee CH, Lee YB, Cho EJ, Yu SJ, Kim YJ, Yoon JH, Lee JH. Empirical
  • Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of
  • Spontaneous Bacterial Peritonitis. Clin Gastroenterol Hepatol. 2020 Jul
  • 2:S1542-3565(20)30909-5. doi: 10.1016/j.cgh.2020.06.046. Epub ahead of print.
  • PMID: 32623007.
  • 11: Chon HY, Seo YS, Lee JI, Kim BS, Jang BK, Kim SG, Suk KT, Kim IH, Lee JW,
  • Chon YE, Kim MY, Jeong SW, Lee HA, Yim SY, Um SH, Lee HW, Lee KS, Song JE, Lee
  • CH, Chung WJ, Hwang JS, Yoo JJ, Kim YS, Kim DJ, Lee CH, Yu JH, Ha YJ, Kim MN,
  • Lee JH, Hwang SG, Kang SH, Baik SK, Jang JY, Suh SJ, Jung YK, Kim BK, Park JY,
  • Kim DY, Ahn SH, Han KH, Yim HJ, Kim SU; Korean Transient Elastography Study
  • Group. Dynamics of liver stiffness-based risk prediction model during antiviral
  • therapy in patients with chronic hepatitis B. Eur J Gastroenterol Hepatol. 2020
  • Jun 11. doi: 10.1097/MEG.0000000000001794. Epub ahead of print. PMID: 32541238.
  • 12: Park SW, Kim TH, Ham SY, Um SH, Goh HG, Lee S, Lee HA, Yim SY, Seo YS, Yim
  • HJ, An H, Oh YW. Clinical implications of thoracic duct dilatation in patients
  • with chronic liver disease. Medicine (Baltimore). 2020 May 29;99(22):e19889.
  • doi: 10.1097/MD.0000000000019889. PMID: 32481363.
  • 13: Lee HA, Lee HW, Kim IH, Park SY, Sinn DH, Yu JH, Seo YS, Um SH, Lee JI, Lee
  • KS, Lee CH, Tak WY, Kweon YO, Kang W, Paik YH, Lee JW, Suh SJ, Jung YK, Kim BK,
  • Park JY, Kim DY, Ahn SH, Han KH, Yim HJ, Kim SU. Extremely low risk of
  • hepatocellular carcinoma development in patients with chronic hepatitis B in
  • immune-tolerant phase. Aliment Pharmacol Ther. 2020 Jul;52(1):196-204. doi:
  • 10.1111/apt.15741. Epub 2020 May 26. PMID: 32452564.
  • 14: Kim TH, Yun SG, Choi J, Goh HG, Lee HA, Yim SY, Choi SJ, Lee YS, Yoon EL,
  • Jung YK, Seo YS, Kim JH, Yim HJ, Yeon JE, Byun KS, Um SH. Differential Impact of
  • Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver
  • Cirrhosis According to MELD and Child-Pugh Scores. J Korean Med Sci. 2020 May
  • 18;35(19):e129. doi: 10.3346/jkms.2020.35.e129. PMID: 32419396; PMCID:
  • PMC7234861.
  • 15: Lim TS, Lee HW, Lee JI, Kim IH, Lee CH, Jang BK, Chung WJ, Yim HJ, Suh SJ,
  • Seo YS, Lee HA, Yu JH, Lee JW, Kim SG, Kim YS, Park SY, Tak WY, Kim SS, Cheong
  • JY, Jeong SW, Jang JY, Rou WS, Lee BS, Kim SU; Korean Transient Elastography
  • Study Group. Predictive score for hepatocellular carcinoma after hepatitis B e
  • antigen loss in patients treated with entecavir or tenofovir. J Viral Hepat.
  • 2020 Oct;27(10):1052-1060. doi: 10.1111/jvh.13316. Epub 2020 May 28. PMID:
  • 32383246.
  • 16: Lee HA, Kim BK, Kim SU. Clinical relevance of dynamic risk assessment for
  • developing hepatocellular carcinoma during prolonged antiviral therapy. J
  • Hepatol. 2020 Jul;73(1):222-223. doi: 10.1016/j.jhep.2020.02.023. Epub 2020 Apr
  • 1. PMID: 32247682.
  • 17: Kim MA, Kim SU, Sinn DH, Jang JW, Lim YS, Ahn SH, Shim JJ, Seo YS, Baek YH,
  • Kim SG, Kim YS, Kim JH, Choe WH, Yim HJ, Lee HW, Kwon JH, Lee SW, Jang JY, Kim
  • HY, Park Y, Kim GA, Yang H, Lee HA, Koh M, Lee YS, Kim M, Chang Y, Kim YJ, Yoon
  • JH, Zoulim F, Lee JH. Discontinuation of nucleos(t)ide analogues is not
  • associated with a higher risk of HBsAg seroreversion after antiviral-induced
  • HBsAg seroclearance: a nationwide multicentre study. Gut. 2020
  • Dec;69(12):2214-2222. doi: 10.1136/gutjnl-2019-320015. Epub 2020 Mar 24. PMID:
  • 32209606.
  • 18: Lee HA, Seo YS, Kim SU. Risk of Hepatocellular Carcinoma With Tenofovir vs
  • Entecavir in Patients With Chronic Hepatitis B. Gastroenterology. 2020
  • Jun;158(8):2310-2311. doi: 10.1053/j.gastro.2019.11.314. Epub 2020 Mar 19. PMID:
  • 32201178.
  • 19: Kim SU, Seo YS, Lee HA, Kim MN, Lee EJ, Shin HJ, Lee YR, Lee HW, Park JY,
  • Kim DY, Ahn SH, Han KH, Um SH, Tak WY, Kweon YO, Kim BK, Park SY. Hepatocellular
  • Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy
  • for Hepatitis B: A Multicenter Study. Cancer Epidemiol Biomarkers Prev. 2020
  • Apr;29(4):832-837. doi: 10.1158/1055-9965.EPI-19-0614. Epub 2020 Jan 27. PMID:
  • 31988073.
  • 20: Lee JS, Lee HA, Jeon MY, Lim TS, Kim BK, Park JY, Kim DY, Ahn SH, Um SH, Han
  • KH, Seo YS, Kim SU. Establishment and validation of a risk prediction model in
  • patients with hepatocellular carcinoma treated with transarterial
  • radioembolization. Eur J Gastroenterol Hepatol. 2020 Jun;32(6):739-747. doi:
  • 10.1097/MEG.0000000000001585. PMID: 31764406.
  • 21: Kim TH, Chang JM, Um SH, Jee H, Lee YR, Lee HA, Yim SY, Han NY, Lee JM, Choi
  • HS, Kim ES, Yu YD, Keum B, Kim MJ, An H, Park BJ, Seo YS, Kim DS, Yim HJ, Cho
  • SB, Jeen YT, Lee HS, Chun HJ, Kim YH, Kim CD. Comparison of 2 curative treatment
  • options for very early hepatocellular carcinoma: Efficacy, recurrence pattern,
  • and retreatment. Medicine (Baltimore). 2019 Jun;98(26):e16279. doi:
  • 10.1097/MD.0000000000016279. PMID: 31261600; PMCID: PMC6616374.
  • 22: Kim SU, Seo YS, Lee HA, Kim MN, Kim EH, Kim HY, Lee YR, Lee HW, Park JY, Kim
  • DY, Ahn SH, Han KH, Hwang SG, Rim KS, Um SH, Tak WY, Kweon YO, Kim BK, Park SY.
  • Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus
  • Infection Receiving Antiviral Therapy. Clin Gastroenterol Hepatol. 2020
  • Mar;18(3):693-699.e1. doi: 10.1016/j.cgh.2019.06.028. Epub 2019 Jun 25. PMID:
  • 31252188.
  • 23: Lee HA, Goh HG, Kim TH, Lee YS, Suh SJ, Jung YK, Choi HS, Kim ES, Kim JH, An
  • H, Seo YS, Yim HJ, Cho SB, Jeen YT, Yeon JE, Chun HJ, Byun KS, Um SH, Kim CD.
  • Evaluation of Treatment Response after Endoscopic Variceal Obturation with
  • Abdominal Computed Tomography. Gut Liver. 2020 Jan 15;14(1):117-124. doi:
  • 10.5009/gnl18392. PMID: 30970445; PMCID: PMC6974331.
  • 24: Kim SU, Seo YS, Lee HA, Kim MN, Lee YR, Lee HW, Park JY, Kim DY, Ahn SH, Han
  • KH, Hwang SG, Rim KS, Um SH, Tak WY, Kweon YO, Kim BK, Park SY. A multicenter
  • study of entecavir vs. tenofovir on prognosis of treatment-naive chronic
  • hepatitis B in South Korea. J Hepatol. 2019 Sep;71(3):456-464. doi:
  • 10.1016/j.jhep.2019.03.028. Epub 2019 Apr 6. PMID: 30959156.
  • 25: Lee HA, Kim SU, Seo YS, Lee YS, Kang SH, Jung YK, Kim MY, Kim JH, Kim SG,
  • Suk KT, Jung SW, Jang JY, An H, Yim HJ, Um SH. Prediction of the varices needing
  • treatment with non-invasive tests in patients with compensated advanced chronic
  • liver disease. Liver Int. 2019 Jun;39(6):1071-1079. doi: 10.1111/liv.14036. Epub
  • 2019 Feb 6. PMID: 30589490.
  • 26: Kim TH, Lee HA, Seo YS, Lee YR, Yim SY, Lee YS, Suh SJ, Jung YK, Kim JH, An
  • H, Yim HJ, Yeon JE, Byun KS, Um SH; Korean Study Group of Portal Hypertension.
  • Assessment and prediction of acute kidney injury in patients with decompensated
  • cirrhosis with serum cystatin C and urine N-acetyl-β-D-glucosaminidase. J
  • Gastroenterol Hepatol. 2019 Jan;34(1):234-240. doi: 10.1111/jgh.14387. Epub 2018
  • Aug 21. PMID: 30062791.
  • 27: Kim TH, Lee EJ, Choi JH, Yim SY, Lee S, Kang J, Lee YR, Lee HA, Choi HS, Kim
  • ES, Keum B, Seo YS, Yim HJ, Jeen YT, Chun HJ, Lee HS, Kim CD, Woo HG, Um SH.
  • Identification of novel susceptibility loci associated with hepatitis B surface
  • antigen seroclearance in chronic hepatitis B. PLoS One. 2018 Jul
  • 5;13(7):e0199094. doi: 10.1371/journal.pone.0199094. PMID: 29975729; PMCID:
  • PMC6033413.
  • 28: Gu DH, Kim MY, Seo YS, Kim SG, Lee HA, Kim TH, Jung YK, Kandemir A, Kim JH,
  • An H, Yim HJ, Yeon JE, Byun KS, Um SH. Clinical usefulness of psoas muscle
  • thickness for the diagnosis of sarcopenia in patients with liver cirrhosis. Clin
  • Mol Hepatol. 2018 Sep;24(3):319-330. doi: 10.3350/cmh.2017.0077. Epub 2018 Apr
  • 30. PMID: 29706058; PMCID: PMC6166111.
  • 29: Kim TH, Ku DH, Um SH, Lee HA, Park SW, Chang JM, Yim SY, Suh SJ, Jung YK,
  • Seo YS, Kim JH, Yim HJ, Yeon JE, Byun KS, Ahn H. How can we improve the
  • performance of Model for End-Stage Liver Disease sodium score in patients with
  • hepatitis B virus-related decompensated liver cirrhosis commencing antiviral
  • treatment? J Gastroenterol Hepatol. 2018 Feb 20. doi: 10.1111/jgh.14128. Epub
  • ahead of print. PMID: 29462844.
  • 30: Kim BS, Seo YS, Kim YS, Lee CH, Lee HA, Um SH, Yoo JJ, Kim SG, Suh SJ, Jung
  • YK, Ahn SH, Han KH, Yim HJ, Kim SU; Korean Transient Elastography Study Group.
  • Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver
  • stiffness through antiviral agents in hepatitis B virus-related advanced
  • fibrosis or cirrhosis. J Gastroenterol Hepatol. 2018 Feb;33(2):503-510. doi:
  • 10.1111/jgh.13854. PMID: 28666070.
  • 31: Seo HY, Lee HA, Ko SY, Wang JH, Kim JH, Choe WH, Kwon SY. Clinical impact of
  • the early alanine amininotransferase flare during tenofovir monotherapy in
  • treatment-naive patients with chronic hepatitis B. Clin Mol Hepatol. 2017
  • Jun;23(2):154-159. doi: 10.3350/cmh.2016.0067. Epub 2017 May 8. PMID: 28479588;
  • PMCID: PMC5497666.
  • 32: Park SW, Seo YS, Lee HA, Park SJ, Kim TH, Lee JM, Suh SJ, Choi HS, Kim ES,
  • Keum B, Jung YK, Kim JH, An H, Yim HJ, Jeen YT, Yeon JE, Lee HS, Chun HJ, Byun
  • KS, Um SH, Kim CD. Changes in Cardiac Varices and Their Clinical Significance
  • after Eradication of Esophageal Varices by Band Ligation. Can J Gastroenterol
  • Hepatol. 2016;2016:2198163. doi: 10.1155/2016/2198163. Epub 2016 Dec 26. PMID:
  • 28116285; PMCID: PMC5220445.
  • 33: Park SJ, Kim YK, Seo YS, Park SW, Lee HA, Kim TH, Suh SJ, Jung YK, Kim JH,
  • An H, Yim HJ, Jang JY, Yeon JE, Byun KS. Cyanoacrylate injection versus band
  • ligation for bleeding from cardiac varices along the lesser curvature of the
  • stomach. Clin Mol Hepatol. 2016 Dec;22(4):487-494. doi: 10.3350/cmh.2016.0050.
  • Epub 2016 Dec 25. PMID: 28081588; PMCID: PMC5266343.
  • 34: Lee HA, Seo YS, Park SW, Park SJ, Kim TH, Suh SJ, Jung YK, Kim JH, An H, Yim
  • HJ, Yeon JE, Byun KS, Um SH. Hepatitis B surface antigen titer is a good
  • indicator of durable viral response after entecavir off-treatment for chronic
  • hepatitis B. Clin Mol Hepatol. 2016 Sep;22(3):382-389. doi:
  • 10.3350/cmh.2016.0047. Epub 2016 Sep 25. PMID: 27729633; PMCID: PMC5066377.
  • 35: Park SW, Um SH, Lee HA, Kim SH, Sim Y, Yim SY, Seo YS, Ryu HS. Mycophenolate
  • mofetil as an alternative treatment for autoimmune hepatitis. Clin Mol Hepatol.
  • 2016 Jun;22(2):281-5. doi: 10.3350/cmh.2015.0040. Epub 2016 Jun 1. PMID:
  • 27246353; PMCID: PMC4946399.
  • 36: Lee HA, Shim HG, Seo YH, Choi SJ, Lee BJ, Lee YH, Ji JD, Kim JH, Song GG.
  • Panenteritis as an Initial Presentation of Systemic Lupus Erythematosus. Korean
  • J Gastroenterol. 2016 Feb;67(2):107-11. doi: 10.4166/kjg.2016.67.2.107. PMID:
  • 26907488.